JPS52153946A - Cyclic amino acid - Google Patents

Cyclic amino acid

Info

Publication number
JPS52153946A
JPS52153946A JP6874277A JP6874277A JPS52153946A JP S52153946 A JPS52153946 A JP S52153946A JP 6874277 A JP6874277 A JP 6874277A JP 6874277 A JP6874277 A JP 6874277A JP S52153946 A JPS52153946 A JP S52153946A
Authority
JP
Japan
Prior art keywords
amino acid
cyclic amino
cyclic
acid
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6874277A
Other languages
Japanese (ja)
Other versions
JPS5633385B2 (en
Inventor
Harutensutain Yohanesu
Satsutsuingeru Geruharudo
Furantsu Rainhoru Manfuretsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of JPS52153946A publication Critical patent/JPS52153946A/en
Publication of JPS5633385B2 publication Critical patent/JPS5633385B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
JP6874277A 1976-06-12 1977-06-10 Cyclic amino acid Granted JPS52153946A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2626467A DE2626467C2 (en) 1976-06-12 1976-06-12 1- (N-Isopropylaminomethyl) -cyclohexaneacetic acid, process for the preparation thereof and medicaments containing this compound

Publications (2)

Publication Number Publication Date
JPS52153946A true JPS52153946A (en) 1977-12-21
JPS5633385B2 JPS5633385B2 (en) 1981-08-03

Family

ID=5980432

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6874277A Granted JPS52153946A (en) 1976-06-12 1977-06-10 Cyclic amino acid

Country Status (4)

Country Link
JP (1) JPS52153946A (en)
AU (1) AU508229B2 (en)
CA (1) CA1094097A (en)
DE (1) DE2626467C2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02132299A (en) * 1988-11-14 1990-05-21 Tokai Rubber Ind Ltd Waterproof construction method
DE3928182A1 (en) * 1989-08-25 1991-02-28 Goedecke Ag METHOD FOR PRODUCING GABAPENTIN
PH27359A (en) * 1989-08-25 1993-06-21 Warner Lambert Co Process for cyclic amino acid anticonvulsant compounds
BR9708200A (en) * 1996-03-14 1999-07-27 Warner Lambert Co Cyclic amino acids substituted as pharmaceutical agents
GB2362646A (en) * 2000-05-26 2001-11-28 Warner Lambert Co Cyclic amino acid derivatives useful as pharmaceutical agents

Also Published As

Publication number Publication date
AU508229B2 (en) 1980-03-13
DE2626467A1 (en) 1977-12-29
DE2626467C2 (en) 1984-11-22
AU2602477A (en) 1978-12-14
CA1094097A (en) 1981-01-20
JPS5633385B2 (en) 1981-08-03

Similar Documents

Publication Publication Date Title
AU2912777A (en) Cyclic peptide derivatives
JPS5436275A (en) Cyclic amino acids
AU513892B2 (en) Cyclic amino acid derivatives
HK56683A (en) Triiodoisophthalic acid amides
JPS539314A (en) Injection solution
MY8500264A (en) Peptides
GB1538920A (en) Cyclic diorganopolysiloxanes
AU513702B2 (en) Peptides
JPS52144669A (en) 122azaprostanic acid
JPS51133245A (en) Nnarylanthranyl acid
JPS535119A (en) Ureidoacetohydroxamic acid
JPS5340755A (en) Novel cyclic compound
AU2727977A (en) Peptides
ZA774388B (en) Novel phenoxy-phenoxy-alkanecarboxylic acid derivatives
JPS52153946A (en) Cyclic amino acid
JPS5484544A (en) Alphaahalomethyl amino acid
AU2592877A (en) Novel carbamic acid oxime-esters
AU1522876A (en) D1-and 8r-9-fluoro-prostadianoic acid
AU2530577A (en) Cyclic amides
AU2051676A (en) 7-acylamido-3-cephem-4-carboxylic acid
JPS5287142A (en) New cyclic amino acid
JPS53111060A (en) Alphaaaminoxyacyl grouppcontaining peptide
JPS5331630A (en) Sulfurrcontaining nnbenzylamino acid
JPS5283613A (en) Novel benzylaminoalkane acid
JPS5283525A (en) Prostanic acid analogs